SparingVision
Developer of a medical therapy designed to treat Retinitis Pigmentosa which is part of Inherited Retinal Diseases. The company's offerings include a drug candidate to treat retinitis pigmentosa, the m...
Valuation
$158.9M
Latest known
Share Price
N/A
Total Raised
$205M
Last Round
N/A